JP2018504141A5 - - Google Patents

Download PDF

Info

Publication number
JP2018504141A5
JP2018504141A5 JP2017556782A JP2017556782A JP2018504141A5 JP 2018504141 A5 JP2018504141 A5 JP 2018504141A5 JP 2017556782 A JP2017556782 A JP 2017556782A JP 2017556782 A JP2017556782 A JP 2017556782A JP 2018504141 A5 JP2018504141 A5 JP 2018504141A5
Authority
JP
Japan
Prior art keywords
government
awarded
health
certain rights
national institutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017556782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018504141A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/013765 external-priority patent/WO2016118433A1/en
Publication of JP2018504141A publication Critical patent/JP2018504141A/ja
Publication of JP2018504141A5 publication Critical patent/JP2018504141A5/ja
Pending legal-status Critical Current

Links

JP2017556782A 2015-01-20 2016-01-17 非標的化アデノウイルス変異体および関連する方法 Pending JP2018504141A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562105284P 2015-01-20 2015-01-20
US62/105,284 2015-01-20
PCT/US2016/013765 WO2016118433A1 (en) 2015-01-20 2016-01-17 Detargeted adenovirus variants and related methods

Publications (2)

Publication Number Publication Date
JP2018504141A JP2018504141A (ja) 2018-02-15
JP2018504141A5 true JP2018504141A5 (enExample) 2019-02-07

Family

ID=56417617

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017556782A Pending JP2018504141A (ja) 2015-01-20 2016-01-17 非標的化アデノウイルス変異体および関連する方法

Country Status (4)

Country Link
US (3) US10376549B2 (enExample)
EP (1) EP3247807B1 (enExample)
JP (1) JP2018504141A (enExample)
WO (1) WO2016118433A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014153204A1 (en) 2013-03-14 2014-09-25 Salk Institute For Biological Studies Oncolytic adenovirus compositions
JP6764859B2 (ja) 2014-09-24 2020-10-07 ソーク インスティテュート フォー バイオロジカル スタディーズ 腫瘍崩壊性腫瘍ウイルスおよび使用の方法
WO2017147269A1 (en) 2016-02-23 2017-08-31 Salk Institute For Biological Studies Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
CA3013637A1 (en) 2016-02-23 2017-08-31 Salk Institute For Biological Studies High throughput assay for measuring adenovirus replication kinetics
FI3436591T3 (fi) * 2016-03-31 2023-03-30 The European Molecular Biology Laboratory Adenoviruksen kuoriproteiinista johdetut kuljetusvälineet
WO2018111767A1 (en) 2016-12-12 2018-06-21 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof
GB201802539D0 (en) * 2018-02-16 2018-04-04 Univ College Cardiff Consultants Ltd Modified adenoviruses
WO2019199859A1 (en) 2018-04-09 2019-10-17 Salk Institute For Biological Studies Oncolytic adenovirus compositions with enhanced replication properties
EP3812465A1 (en) * 2019-10-21 2021-04-28 Universität Ulm Adenovirus comprising a modified adenovirus hexon protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1601438A (enExample) 1968-10-17 1970-08-24
EP0571549A4 (en) * 1991-02-14 1995-03-15 Jolla Cancer Res Found NEW SPECIFICITY OF INTEGRIN FOR HIV PROTEIN Tat.
US5559099A (en) 1994-09-08 1996-09-24 Genvec, Inc. Penton base protein and methods of using same
AU767975B2 (en) 1998-09-11 2003-11-27 Genvec, Inc. Alternatively targeted adenovirus
US20060057553A1 (en) * 2000-05-30 2006-03-16 Estuardo Aguilar-Cordova Chimeric viral vectors for gene therapy
EP1572718A4 (en) * 2001-04-04 2006-03-15 Univ Rochester ALPHA NU BETA-3 INTEGRIN BINDING POLYPEPTIDE ANTIBODY AND THEIR USE
KR100491299B1 (ko) * 2001-09-29 2005-05-24 학교법인연세대학교 개선된 질환 치료 효과를 갖는 재조합 아데노바이러스 및그를 포함하는 약제학적 조성물
JP4488290B2 (ja) * 2002-01-24 2010-06-23 ザ・スクリップス・リサーチ・インスティテュート 効率的ターゲティングのためのファイバーシャフト変異
JP4328116B2 (ja) * 2003-03-25 2009-09-09 国立医薬品食品衛生研究所長 変異型アデノウイルスベクター
US20060281090A1 (en) * 2003-05-01 2006-12-14 University Of Washington Uw Tech Transfer- Invention Licensing Capsid-modified adenovirus vectors and methods of using the same
WO2007094653A1 (en) * 2006-02-13 2007-08-23 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles.
CN102014948A (zh) * 2008-02-07 2011-04-13 安德鲁·贝克 腺病毒向性的调节
CA2779632C (en) * 2009-11-09 2019-08-20 Jason Gall Simian adenovirus and methods of use

Similar Documents

Publication Publication Date Title
JP2018504141A5 (enExample)
JP2021502979A5 (enExample)
JP2021503478A5 (enExample)
WO2018081648A3 (en) ANTI-MIC ANTIBODIES AND METHODS OF USE
JP2021500894A5 (enExample)
JP2018012698A5 (enExample)
JP2018100276A5 (enExample)
WO2018106776A3 (en) Anti-tau antibodies and methods of their use
HUE054548T2 (hu) Amino-triazolopiridin vegyületek és azok alkalmazása rák kezelésében
JP2016196495A5 (enExample)
JP2018533683A5 (enExample)
HUE054103T2 (hu) Izokinolin-3-il-karboxamidok, ezek elõállítása és alkalmazása
WO2016077381A8 (en) Anti-interleukin-33 antibodies and uses thereof
WO2015179658A3 (en) Anti-gpc3 antibodies and immunoconjugates
JP2019536002A5 (enExample)
HUE062189T2 (hu) Aktivin-ACTRII-antagonisták és alkalmazások mielodiszpláziás szindróma kezelésére
TR201810635T4 (tr) Anti-jagged1 antikorları ve kullanım yöntemleri.
TWD173737S (zh) 肌肉鍛鍊機器
JP2018064407A5 (enExample)
JP2017537928A5 (enExample)
EP3415518A4 (en) MACROCYCLUS AND COMPOSITION THEREOF
JP2015186128A5 (enExample)
SG11201900459RA (en) Mg53 mutants, methods of making the same, and uses thereof
JP2015173751A5 (enExample)
HUE063621T2 (hu) ß-interferon elleni ellenanyagok és alkalmazásuk